Masterolone Forte 200 mg Restek Laboratories

Masterolone Forte 200 mg Restek Laboratories: instructions for use

The anabolic steroid Drostanolone is widely known in sports circles. It can be used alone or in combination with other drugs. Masterolone Forte 200 mg Restek Laboratories – Masterolone Forte Restek Laboratories contains Drostanolone Enanthate. It is a form of steroid that has a longer duration of action than propionate. This formulation allows you to inject less frequently, which is more convenient.

How Masterolone Forte 200 mg Restek Laboratories affects the body

Drostanolone itself is not used in mass recruitment courses. Here are its main properties:

• maintenance of muscle mass during drying;
• slight diuretic effect (fluid excretion);
• visual change of the figure (relief);
• increased muscle hardness and strength;
• fat burning (up to 7% of the original fat mass);
• increased endurance;
• suppression of catabolism (muscle degradation process).

These qualities make Masterolone Forte 200 mg Restek Laboratories a popular product in:

• bodybuilding;
• dynamophilia;
• athletics;
• weightlifting and other sports.

The drug helps to maintain the weight class. If an athlete goes through a drying cycle, drostanolone will help him not to lose the gained muscles, but only to get rid of fat and water, while improving the external data.

Possible side effects

Taking the drug increases the risk of androgenic side effects. Therefore, it is recommended to use it only for men. For women, the drug is contraindicated due to virilisation. This is the process by which women develop secondary male sexual characteristics.

In men it is possible:

• acne and oily skin;
• baldness (if predisposed);
• excessive hair growth on the face and body;
• enlarged prostate (growth of glandular tissue);
• weakening of endogenous testosterone synthesis.

There is also an increase in aggression.

Concomitant medications, as well as post-cycle therapy, help to eliminate the problems.

Course of taking Masterolone Forte 200 mg Restek Laboratories

Since enanthate is the longest-lasting form of the steroid, it can be taken once a week. The half-life of the active substance is 10 days, so this frequency of administration is sufficient to maintain the concentration of drostanolone at the desired level.

Dosages vary and depend on the needs of the athlete. Basically it is 400-500 mg per week. Your doctor will help you determine the amount of medication you need. Masterolon Forte Restek 10ml x 200mg is convenient to dose. It is administered intramuscularly.

The duration of the course is determined individually, depending on whether the achieved effect is sufficient for the athlete. But if it lasts longer than 4 weeks, it is recommended to take maintenance medication. And when you stop the course, you should definitely connect funds to restore the production of your own testosterone. In this case, the positive effects of the steroid will be corrected and the negative effects will not appear.

List of references

1. Farooqi V, van den Berg J, Sparreboom A, et al. Comparative analysis of testosterone and dihydrotestosterone uptake by prostate cancer cells and the expression of some steroidogenic enzymes. J Steroid Biochem Mol Biol. 2011;125(3-5):176-184. doi:10.1016/j.jsbmb.2011.04.010
2. Köhn FM, Schöber C, Trefz FK, et al. Androgen metabolism of human benign prostatic tissue in vitro: a comparative study of two different 5 alpha-reductase inhibitors and cyproterone acetate. Prostate. 1993;22(1):59-70. doi:10.1002/pros.2990220108
3. Meikle AW, Mazer NA, Moellmer JF, Stringham JD. Enhanced 5 alpha-reductase activity in patients with the nephrotic syndrome. J Clin Endocrinol Metab. 1992;74(6):1156-1161. doi:10.1210/jcem.74.6.1373221
4. Schröder FH, Roobol MJ. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer. Curr Opin Urol. 2009;19(3):227-231. doi:10.1097/MOU.0b013e32832d3c07
5. Singh AB, Hsia S, Alaupovic P, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002;87(1):136-143. doi:10.1210/jcem.87.1.8141